Introduction {#sec1-1}
============

Amyotrophic lateral sclerosis is a fatal neurodegenerative disease. To date, many related genes and loci have been identified in this disease (Beleza-Meireles and Al-Chalabi, 2009; Maruyama et al., 2010; DeJesus-Hernandez et al., 2011). Mutations in superoxide dismutase 1 (SOD1) account for 20% of cases of familial amyotrophic lateral sclerosis and 5% of sporadic cases (Rosen, 1993). Several mutations of human SOD1 (SOD1^G93A^, SOD1^G37R^, and SOD1^G85R^) have been investigated in a mouse model (Gurney et al., 1994; Bruijn et al., 1997; Cai and Fan, 2013; Ye et al., 2013). Of these mutant forms, SOD1^G93A^ is the most common. Initial studies detected no significant pathology during the early course of the disease (Gurney et al., 1994). However, several recent reports have shown that pathological and physiological changes occur much earlier than previously thought, even at the embryonic stage. Embryonic alterations in motor neuronal morphology induce hyperexcitability in adult-onset SOD1^G93A^ mice (Martin et al., 2013). Studies on neonatal neuronal circuitry have also shown a hyperexcitable disturbance in SOD1^G93A^ mice (van Zundert et al., 2008). Progressive degeneration of lumbar motor neurons in SOD1^G93A^ transgenic mice has also been suggested to occur at birth (Lowry et al., 2001). In addition to mature neural cells, Luo et al. (2007) recently reported an impairment of SDF1/CXCR4 signaling, which regulates neural development *via* the promotion of cell survival and proliferation, in neural stem cells (NSCs) derived from SOD1^G93A^ mice. Abnormalities in embryonic NSCs might result in susceptibility to neurodegeneration at a later stage. Thus, identification of early alterations in NSCs might be crucial to understand amyotrophic lateral sclerosis pathogenesis.

Adenosine monophosphate-activated protein kinase (AMPK) is a central regulator of cellular metabolism. It consists of a catalytic α-subunit and regulatory β- and γ-subunits (Ma et al, 2012). The Thr172 residue of the α-subunit is phosphorylated under specific conditions such as exercise, hypoxia, and oxidative stress (Hardie, 2007). However, the full array of AMPK functions has not yet been elucidated in NSCs, although there have been studies on other neural cell types. For example, AMPK protects embryonic hippocampal neurons from hypoxia-induced cell death and partially guards against oxidative stress-induced cell death in an immortalized cerebellar cell line (Culmsee et al., 2001; Park et al., 2009). Nuclear translocation of AMPK potentiates striatal neurodegeneration (Ju et al., 2011). Furthermore, AMPK regulates forkhead box, class O, mammalian target of rapamycin, and mammalian silent information regulator 2 ortholog (Fulco et al., 2003; Cheng et al., 2004; Greer et al., 2007; Canto et al., 2009), which have been implicated in NSC regulation. Recently, Loken et al. (2012) suggested that AMPK mediates the effects of oxidative stress on neural tube development. It remains to be determined whether AMPK exhibits protective or cell death-inducing effects on NSCs under conditions of oxidative stress.

The aim of the present study was to investigate the effects of hydrogen peroxide (H~2~O~2~)-induced oxidative stress on embryonic NSCs in the SOD1^G93A^ mouse model of amyotrophic lateral sclerosis and evaluate whether AMPK has certain effects on NSCs under conditions of oxidative stress.

Materials and Methods {#sec1-2}
=====================

Isolation and culture of NSCs {#sec2-1}
-----------------------------

Fetal mice used in this study were bred under the strain designations B6SJL-Tg(SOD1^G93A^)1Gur/J and B6SJL-Tg (SOD1)2Gur/J for SOD1^G93A^ transgenic and wild-type SOD1 transgenic mice. They were obtained from Jackson Laboratories (Gurney et al., 1994). Brains were removed from the embryos at embryonic day 14 to isolate NSCs, as described previously (Park et al., 2012), with slight modifications. Animal care and experimental protocols were performed in strict accordance with *the NIH Guide for the Care and Use of Laboratory Animals* and were approved by the Animal Care and Ethics Committee at Peking University Third Hospital, China.

Each embryo was genotyped by genomic polymerase chain reaction (PCR) using primers for the hSOD1 transgene (forward: 5′-CAT CAG CCC TAA TCC ATC TGA-3′; reverse: 5′-CGC GAC TAA CAA TCA AAG TGA-3′). NSCs prepared from SOD1^G93A^ fetal mice (carrying the human SOD1^G93A^ gene) and SOD1^WT^ fetal mice (carrying the human wild-type SOD1 gene) were used for experiments. SOD1^WT^ NSCs served as controls. After the meninges were removed, single cell suspensions were obtained by mechanical dissociation. Then, the cell suspensions were centrifuged at 100 × g for 5 minutes. After discarding the supernatant, the cells were re-suspended with 1 mL complete neurosphere medium. The cells were seeded at a density of 2 × 10^5^/mL in 10 mL complete NSC medium. NSCs were cultured in maintenance medium containing Dulbecco\'s modified Eagle medium/Ham\'s F-12 medium (DMEM/F12) supplemented with serum-free neurobasal growth supplement 2% v/v (B27, Life Technologies, Carlsbad, CA, USA), recombinant human basic fibroblast growth factor (20 ng/mL, PeproTech, Rocky Hill, NJ, USA), and recombinant human epidermal growth factor (20 ng/mL, PeproTech) in a humidified incubator (37°C, 5% CO~2~). Neurospheres with diameters of about 200 μm were sub-cultured after 3--5 days.

Test groups {#sec2-2}
-----------

After genotyping, SOD1^G93A^ NSCs and SOD1^WT^ NSCs were exposed to 0.5 mmol/L H~2~O~2~, 1 mmol/L H~2~O~2~, or normal conditions. To elucidate the role of AMPK in H~2~O~2~-induced apoptosis of NSCs, we employed an AMPK activator (5-aminoimidazole-4-carboxyamide ribonucleoside, AICAR) or inhibitor (compound C). The NSCs were divided into four groups: normal, H~2~O~2~, AICAR (positive control), and H~2~O~2~ plus compound C. The 3% (w/w) H~2~O~2~ solution, AICAR, and compound C were obtained from Sigma-Aldrich (St Louis, MO, USA).

Immunocytochemistry {#sec2-3}
-------------------

NSCs (4 × 10^5^/mL) were cultured on coverslips coated with poly-L-ornithine (Sigma-Aldrich) for 36 hours. The cells were then incubated with the following primary antibodies at 4°C overnight for double immunolabeling: mouse anti-Nestin monoclonal antibody (1:100; Abcam, Cambridge, MA, USA) and rabbit anti-Sox2 monoclonal antibody (1:100; Epitomics, Burlingame, CA, USA). Then, the cells were incubated with anti-rabbit IgG (1:100) and anti-mouse IgG (1:100) secondary antibodies conjugated with Alexa Fluor® 488 or 594 (Invitrogen, Carlsbad, CA, USA) at room temperature for 1 hour. Lastly, the cells were mounted in mounting medium containing 4′,6-diamidino-2-phenylindole (DAPI; Vector Laboratories, Burlingame, CA, USA). Fluorescence images were captured using an upright fluorescence microscope (Leica, Wetzlar, Hesse-Darmstadt, Germany). Controls for negative staining were prepared with PBS in place of the primary antibodies.

Cell viability and proliferation assays {#sec2-4}
---------------------------------------

NSCs were seeded onto poly-L-ornithine-coated 96-well plates at a density of 1 × 10^4^/mL for 36 hours, and then cultured under the four conditions listed above. Then, the culture medium was removed and replaced with normal medium. A total of 10 μL mitochondrial succinic dehydrogenase colorimetric reagent (Cell Counting Kit-8 reagent, Dojindo Laboratories, Kumamoto, Japan) was added to each well according to the manufacturer\'s protocol, followed by incubation for 3 hours at 37°C with 5% CO~2~. The absorbance was measured at 450 nm on a microplate reader (Bio-Rad Laboratories, Hercules, CA, USA) at a reference wavelength of 600 nm.

Flow cytometric analysis {#sec2-5}
------------------------

Fluorescein isothiocyanate and propidium iodide (FITC Annexin V Apoptosis Detection Kit, BD Biosciences, Franklin Lakes, NJ, USA) were used to assess NSC apoptosis. Intact cells were Annexin V(--)/PI(--). Early and late apoptotic cells were Annexin V(+)/PI(--) and Annexin V(+)/PI(+), respectively. Necrotic cells were Annexin V(--)/PI(+).

Western blot analysis {#sec2-6}
---------------------

NSCs were lysed in RIPA lysis buffer (Apply Technologies, Beijing, China) in the presence of protease and phosphatase inhibitors (Sigma-Aldrich) on ice according to the manufacturer\'s instructions. The protein concentration was measured with a BCA™ Protein Assay Kit (Pierce Chemical, Rockford, IL, USA). Samples containing 30 μg protein were separated by SDS-polyacrylamide gel electrophoresis and transferred to nitrocellulose filter membranes (Millipore, Billerica, MA, USA). The membranes were incubated at 4°C overnight with the following primary antibodies: rabbit anti-AMPKα (1:1,000), rabbit anti-phospho-AMPKα (1:1,000), mouse anti-p53 (1:1,000; Cell Signaling Technology, Boston, MA, USA), and goat anti-paired box 3 (Pax3, 1:250; Abcam, Cambridge, MA, USA). A mouse anti-β-actin antibody (1:1,000; Earthox, San Francisco, CA, USA) was used to label β-actin for normalization. The gray value of protein bands was detected using an infrared imaging system (Odyssey, LICOR Biosciences, Lincoln, NE, USA).

RNA preparation and real-time PCR {#sec2-7}
---------------------------------

Total RNA from NSCs was isolated using a single-step RNA extraction reagent (Trizol, Life Technologies) according to the manufacturer\'s instructions. The cDNA was synthesized from 1 μg total RNA using avian myeloblastosis virus reverse transcriptase (Reverse Transcription System, Promega, Madison, WI, USA) and amplified by PCR (GoTaq® qPCR Master Mix, Promega). The PCR conditions were as follows: 95°C for 2 minutes and then 40 cycles of 95°C for 15 seconds and 58°C for 30 seconds. The primer sequences are listed in **[Table 1](#T1){ref-type="table"}**. The expression level of the target gene was normalized to mouse β-actin, and the relative gene expression (2^-ΔΔCt^) was calculated using the previous method (Livak and Schmittgen, 2001).

###### 

Primer sequence and product size of real-time PCR analyses

![](NRR-9-1770-g001)

Statistical analysis {#sec2-8}
--------------------

Data are presented as the mean ± SD. Statistical analyses were performed with SPSS 19.0 software (SPSS, Chicago, IL, USA) using one-way analysis of variance followed by the least significant difference *post-hoc* test. Differences were considered significant at *P* \< 0.05.

Results {#sec1-3}
=======

Culture and identification of mouse embryonic NSCs {#sec2-9}
--------------------------------------------------

SOD1^G93A^ and SOD1^WT^ NSCs were isolated from fetal brains, expanded as neurospheres, and passaged every 3--5 days (**[Figure 1](#F1){ref-type="fig"}**). There was no substantial difference in the formation of neurospheres between the two types of NSCs. In immunofluorescence analyses, most of the cells were positive for the intermediate filament protein Nestin and the transcription factor Sox2 (**[Figure 2](#F2){ref-type="fig"}**), which are markers of NSCs.

![Morphology of neural stem cells prepared from embryos of SOD1^WT^ and SOD1^G93A^ mice at 1, 3, and 5 days after culture (D1, 3, and 5) (inverted microscope).\
Embryonic neural stem cells formed typical neurospheres after *in vitro* culture. SOD1: Superoxide dismutase 1.](NRR-9-1770-g002){#F1}

![Identification of neural stem cells by double immunofluorescence staining of Nestin (red) and Sox2 (green) (immunocytochemistry, fluorescence microscope).\
Nestin and Sox2 were expressed in the neural stem cells derived from mouse embryos. Blue: DAPI-labeled nuclei. SOD1: Superoxide dismutase 1.](NRR-9-1770-g003){#F2}

Effect of H~2~O~2~-induced oxidative stress on the apoptosis of NSCs from SOD1^G93A^ mice {#sec2-10}
-----------------------------------------------------------------------------------------

To evaluate differences in the susceptibilities of SOD1^G93A^ and SOD1^WT^ NSCs to oxidative stress, the NSCs were exposed to H~2~O~2~ (0.5 and 1 mmol/L) for 12 hours. As expected, the viability of the NSCs was significantly decreased by H~2~O~2~ treatment in a dose-dependent manner (**[Figure 3A](#F3){ref-type="fig"}**, *P* = 0.004, *P* = 0.016). Importantly, the viability of SOD1^G93A^ NSCs was significantly more decreased than that of SOD1^WT^ cells when treated with 1 mmol/L H~2~O~2~ (*P* = 0.026). To further investigate the effects of H~2~O~2~ on NSC proliferation, cell viability was examined at several time points (0, 24, 48, and 72 hours). In untreated controls, no significant difference was observed in the proliferation of SOD1^G93A^ and SOD1^WT^ cells (**[Figure 3B](#F3){ref-type="fig"}**). However, when 1 mmol/L H~2~O~2~ was added at 24 hours, cell proliferation was inhibited to 72 hours, and the viability of SOD1^G93A^ NSCs at 72 hours was significantly lower than that of the SOD1^WT^ NSCs. To evaluate the degree of injury induced by H~2~O~2~ in NSCs, apoptosis was assessed by Annexin V-FITC and PI staining using flow cytometry (**[Figure 4A](#F4){ref-type="fig"}**). Consistent with the observations in the cell viability assay, apoptosis was significantly enhanced by H~2~O~2~ treatment. When SOD1^WT^ and SOD1^G93A^ NSCs were not treated with H~2~O~2~, the percentages of apoptotic cells were 13.31 ± 1.21% and 12.57 ± 1.87%, respectively. When SOD1^WT^ and SOD1^G93A^ NSCs were treated with 0.5 mmol/L H~2~O~2~, the percentages of apoptotic cells increased from 13.31 ± 1.21% and 12.57 ± 1.87% to 20.52 ± 3.04% and 23.43 ± 2.45% (*P* = 0.01 and *P* = 0.002), respectively. When SOD1^WT^ and SOD1^G93A^ NSCs were treated with 1 mmol/L H~2~O~2~, the percentage of apoptotic cells increased from 13.31% ± 1.21% and 12.57 ± 1.87% to 26.22 ± 2.47% and 35.06 ± 2.95% (*P* = 0.026 and *P* = 0.001), respectively (**[Figure 4B](#F4){ref-type="fig"}**). In the 1 mmol/L H~2~O~2~ group, the percentage of apoptotic SOD1^G93A^ NSCs was significantly higher than that of SOD1^WT^ cells (*P* = 0.029). These results suggest that SOD1^G93A^ NSCs are more susceptible to oxidative stress induced by H~2~O~2~.

![Neural stem cells (NSCs) in SOD1^G93A^ mice are more susceptible to oxidative injury induced by H~2~O~2~ (cell viability and proliferation assays).\
(A) Effects of H~2~O~2~ on the cell viability of NSCs. The absorbance value of untreated SOD1^WT^ NSCs was set as 100%. (B) Effect of H~2~O~2~ on the pro-liferation of NSCs. \**P* \< 0.05; \*\**P* \< 0.01. Data are presented as the mean ± SD and analyzed using one-way analysis of variance followed by the least significant difference *post-hoc* test. Each set of measurements was performed in triplicate in at least five independent experiments. H~2~O~2~ (--) indicates no treatment; h: hour(s); SOD1: superoxied dismutase 1.](NRR-9-1770-g004){#F3}

![Neural stem cells (NSCs) in SOD1^G93A^ mice are more susceptible to apoptosis induced by H~2~O~2~ (flow cytometry).\
(A) Representative scatter plots showing apoptosis in H~2~O~2~-treated NSCs by Annexin V-FITC and PI staining and flow cytometry. (I) Late apoptotic cells; (II) early apoptotic cells; (III) intact cells; (IV) necrotic cells. (B) Quantification of apoptotic cells. NSCs were cultured for 36 hours and then treated with H~2~O~2~ for 12 hours, followed by apoptosis detection. \**P* \< 0.05; \*\**P* \< 0.01. The values are the mean ± SD of five independent experiments (one-way analysis of variance followed by the least significant difference *post-hoc* test). H~2~O~2~ (--) indicates no treatment. SOD1: Superoxide dismutase 1.](NRR-9-1770-g005){#F4}

AMPK phosphorylation was enhanced in H~2~O~2~-treated SOD1^G93A^ NSCs together with changes in Pax3 and p53 levels {#sec2-11}
------------------------------------------------------------------------------------------------------------------

To address the potential role of AMPK in the apoptosis of SOD1^G93A^ and SOD1^WT^ NSCs, we evaluated phosphorylation of AMPKα (**[Figure 5A](#F5){ref-type="fig"}**). Cells were cultured for 36 hours followed by H~2~O~2~ treatment. Significant increases in the phosphorylation of AMPKα occurred after 12 hours of H~2~O~2~ exposure, which was markedly higher in SOD1^G93A^ NSCs than that in SOD1^WT^ cells in the 1 mmol/L H~2~O~2~ group (**[Figure 5B](#F5){ref-type="fig"}**; *P* = 0.019). AMPK has been also shown to inhibit Pax3 expression in a mouse model of diabetic embryopathy (Wu et al., 2012). To confirm our hypothesis that Pax3 expression is also regulated by AMPK in this model, we examined Pax3 protein levels (**[Figure 5A](#F5){ref-type="fig"}**). As a result, we found that Pax3 protein levels were clearly decreased in NSCs exposed to H~2~O~2~, and these changes were more obvious in SOD1^G93A^ NSCs treated with 1 mmol/L H~2~O~2~. A loss of Pax3 expression has been shown to increase p53 protein levels and apoptosis, resulting in neural tube defects (Chappell et al., 2009). When we examined p53 protein levels (**[Figure 5A](#F5){ref-type="fig"}**), we found an inverse correlation in the concentrations of p53 and Pax3 proteins, *i.e.*, downregulation of Pax3 protein levels enhanced the levels of p53 protein. The above data indicated that the AMPK pathway might be involved in the apoptosis of NSCs induced by H~2~O~2~.

![Adenosine monophosphate-activated protein kinase (AMPK) phosphorylation levels are increased in SOD1^G93A^ neural stem cells (NSCs) by H~2~O~2~ exposure with corresponding changes in Pax3 and p53 levels (western blot analysis).\
(A) Representative western blots displaying expression or activation of AMPK α-subunit (AMPKα), paired box 3 (Pax3), and p53 in NSCs treated with or without H~2~O~2~. β-Actin was used as a loading control. Data below each lane represent the relative gray scale compared with β-actin control bands. Values below SOD1^WT^ NSCs treated without H~2~O~2~ were set as 1. (B) Phosphorylation levels of AMPKα were quantified relative to the total AMPKα level. The expression level in untreated SOD1^WT^ NSCs was set at 100%. \**P* \< 0.05; \*\**P* \< 0.01. Data are presented as the mean ± SD and analyzed using one-way analysis of variance followed by the least significant difference *post-hoc* test. (--): Untreated; WT: superoxide dismutase 1 wild-type neural stem cells; G93A: SOD1^G93A^ neural stem cells; p-AMPKα: phosphorylated AMPKα; t-AMPKα: total AMPKα. SOD1: Superoxide dismutase 1.](NRR-9-1770-g006){#F5}

In addition, we found that the mRNA levels of AMPKα~1~, AMPKα~2~, and p53 were unaffected by H~2~O~2~ treatment (**Figure [6A](#F6){ref-type="fig"}, [B](#F6){ref-type="fig"}, and [D](#F6){ref-type="fig"}**). The downregulation of Pax3 mRNA by H~2~O~2~ treatment was statistically significant, and Pax3 mRNA was significantly lower in SOD1^G93A^ NSCs compared with that in SOD1^WT^ NSCs in the 1 mmol/L H~2~O~2~ group (**[Figure 6C](#F6){ref-type="fig"}**).

![Quantitative real-time PCR analysis of the mRNA expression of adenosine monophosphate (AMP)-activated protein kinase α1 subunit (AMPKα~1~) (A), AMP-activated protein kinase α2 subunit (AMPKα~2~) (B), paired box 3 (Pax3) (C), and p53 (D) in neural stem cells under different treatment conditions.\
H~2~O~2~ (--): Untreated. \**P* \< 0.05; \*\**P* \< 0.01. Data are presented as the mean ± SD and analyzed using one-way analysis of variance followed by the least significant difference *post-hoc* test. SOD1: Superoxide dismutase 1.](NRR-9-1770-g007){#F6}

Inhibition of AMPK activity cancelled the effects of H~2~O~2~ on the apoptosis of NSCs {#sec2-12}
--------------------------------------------------------------------------------------

To further confirm the role of AMPK in H~2~O~2~-induced apoptosis of NSCs, we employed an AMPK activator (AICAR, 1 mmol/L) and inhibitor (compound C, 1 μmol/L). Cells were maintained in growth medium for 36 hours prior to treatment with different agents. Based on our previous results, 1 mmol/L H~2~O~2~ was used in these experiments. Compared with controls, NSCs treated with AICAR for 12 hours in the absence of H~2~O~2~ demonstrated a decrease in viability, although this effect was not significant compared with that in H~2~O~2~-treated cells (**[Figure 7A](#F7){ref-type="fig"}**; *P* = 0.009 and *P* = 0.001). When NSCs were preincubated for 1 hour with compound C followed by H~2~O~2~ treatment for 12 hours, cell viability was slightly but significantly reversed compared with that in the 1 mmol/L H~2~O~2~ group. The cell viability of SOD1^G93A^ NSCs was also similar to SOD1^WT^ cells when treated with 1 mmol/L H~2~O~2~ plus compound C (**[Figure 7A](#F7){ref-type="fig"}**; *P* = 0.431). Similar results were obtained in cell apoptosis assays (**[Figure 7B](#F7){ref-type="fig"}**). Next, we investigated the effect of AICAR and compound C on the phosphorylation of AMPKα and protein levels of Pax3 and p53 in NSCs using western blot analyses (**[Figure 8A](#F8){ref-type="fig"}**). Similar to H~2~O~2~ treatment, phosphorylation of AMPKα was increased in response to AICAR. In contrast, compound C inhibited H~2~O~2~-induced AMPKα phosphorylation. There was no significant difference in AMPKα phosphorylation of SOD1^G93A^ and SOD1^WT^ NSCs when treated with 1 mmol/L H~2~O~2~ plus compound C (**[Figure 8B](#F8){ref-type="fig"}**). Pax3 expression was inversely correlated with the changes in AMPKα phosphorylation of H~2~O~2~- and AICAR-treated NSCs with AICAR treatment producing the most pronounced decrease in Pax3 levels. Pax3 expression was partially restored by compound C in H~2~O~2~-treated NSCs (**[Figure 8A](#F8){ref-type="fig"}**). Moreover, p53 protein levels were enhanced by AICAR, whereas the effects of H~2~O~2~ on p53 were partially blocked by compound C. In summary, inhibition of AMPK activity attenuated the effect of H~2~O~2~ on NSCs. The above data indicate that AMPK activation triggers p53-dependent apoptosis of NSCs induced by H~2~O~2~.

![Effects of adenosine monophosphate-activated protein kinase (AMPK) activator 5-aminoimidazole-4-carboxyamide ribonucleoside (AICAR) and inhibitor compound (CC) on the viability and apoptosis of neural stem cells (NSCs).\
(A) Cell viability was significantly affected by the addition of AICAR or compound C. The absorbance value of untreated superoxide dismutase 1 wild-type (SOD1^WT^) NSCs was set at 100%. (B) Quantitative assessment of NSC apoptosis by AnnexinV-FITC and PI staining and flow cytometry under different treatment conditions. H~2~O~2~ (--): Untreated. \**P* \< 0.05; \*\**P* \< 0.01. Data are presented as the mean ± SD and analyzed using one-way analysis of variance followed by the least significant difference *post-hoc* test. FITC: Fluoresscen isothiocyante; PI: propidium iodide.](NRR-9-1770-g008){#F7}

![Effects of adenosine monophosphate-activated protein kinase (AMPK) activator 5-aminoimidazole-4-carboxyamide ribonucleoside (AICAR) and inhibitor compound (CC) on the phosphorylation of AMPKα and protein levels of Pax3 and p53 in neural stem cells (NSCs) (western blot analysis).\
(A) Representative western blots displaying the phosphorylation of AMPKα, paired box 3 (Pax3), and p53 protein in NSCs exposed to different fac-tors. β-Actin was used as a loading control. Data below each lane represent the relative gray scale compared with β-actin control bands. (B) Phos-phorylation levels of AMPKα relative to total AMPKα levels. The expression level in untreated superoxide dismutase 1 wild-type (SOD1^WT^) NSCs was set at 100%. Data are presented as the mean ± SD and analyzed using one-way analysis of variance followed by the least significant difference *post-hoc* test. p-AMPKα: Phosphorylated AMPKα; t-AMPKα: total AMPKα; H~2~O~2~ (--): Untreated; WT: SOD1^WT^ NSCs; G93A: SOD1^G93A^ NSCs \**P* \< 0.05; \*\**P* \< 0.01; SOD1: Superoxide dismutase 1.](NRR-9-1770-g009){#F8}

Discussion {#sec1-4}
==========

The mechanism underlying mutant SOD1 toxicity has not yet been elucidated. Although some mutants of SOD1 (such as A4V and G85R) exhibit reduced dismutase activity, other mutants (such as G37R and G93A) retain full dismutase activity (Yim et al., 1996). Because SOD1^G93A^ displays full dismutase activity, the mutation itself may not result in apoptosis, which is consistent with the observation that the cell viability of SOD1^G93A^ and SOD1^WT^ NSCs is similar under normal conditions. However, the SOD1 mutation might make cells more vulnerable to oxidative stress. For example, Rogers and Schor (2010) indicated that proteins involved in neurodegenerative disease often play critical roles in early development of the central nervous system. SOD1 contributes to the organogenesis of embryos, including neurogenesis (Kase et al., 2012). Therefore, it is unclear why the disease appears later in life. Smith proposed a "two-hit" hypothesis for neurodegenerative diseases such as Alzheimer\'s disease, Parkinson\'s disease, and amyotrophic lateral sclerosis (Zhu et al., 2004, 2007). The first "hit" is usually a genetic factor, which presents a vulnerability, and the second "hit" is an environmental factor that triggers the neurodegenerative process. This hypothesis is consistent with our observation that, compared with SOD1^WT^ NSCs, more SOD1^G93A^ NSCs were apoptotic when treated with 1 mmol/L H~2~O~2~. This finding demonstrated that expression of the SOD1^G93A^ gene increased the vulnerability of NSCs to oxidative stress. The "two-hit" hypothesis may also explain why Alzheimer\'s disease, Parkinson\'s disease, and amyotrophic lateral sclerosis are age-related diseases. Reactive oxygen species gradually increase with age. When reactive oxygen species increase to a specific threshold, neuronal degeneration may be triggered in some individuals with the mutant gene.

Li et al. (2012) examined rat neural progenitor cells and found that SOD1^G93A^ overexpression increases the cellular sensitivity to oxidative stress. However, elucidation of the pathway underlying SOD1^G93A^ susceptibility has not been studied. In the present study, significant increases in the phosphorylation of AMPKα and relevant changes in Pax3 and p53 levels occurred in the presence of H~2~O~2~, indicating involvement of the AMPK/Pax3/p53 signaling pathway in the H~2~O~2~-induced apoptosis of NSCs. Interestingly, phosphorylation of AMPKα and subsequent changes in Pax3 and p53 levels were markedly greater in SOD1^G93A^ NSCs compared with those in SOD1^WT^ cells in the 1 mmol/L H~2~O~2~ group. These data suggest that activation of the AMPK pathway likely leads to excessive apoptosis of SOD1^G93A^ NSCs. Further experiments using the AMPK activator and inhibitor also clearly indicated that activation of the AMPK/Pax3/p53 pathway mediated the susceptibility of SOD1^G93A^ mutant cells to oxidative stress. However, the AMPK activator and inhibitor had partial effects with regard to H~2~O~2~ alone, which implies the involment of other cell death signaling pathways such as caspases.

Activated AMPK can also undergo nuclear translocation and regulate gene expression by phosphorylating nuclear proteins (Ju et al., 2011). Based on the data in **Figures [5](#F5){ref-type="fig"}** and **[6](#F6){ref-type="fig"}**, AMPK inhibited Pax3 transcription, but the underlying mechanism requires further study. In addition, the protein levels of p53 were inversely correlated with those of Pax3, although the mRNA levels of p53 showed no significant change upon downregulation of Pax3 mRNA. These results were consistent with a previous study demonstrating that Pax3 induces p53 ubiquitination and degradation independent of transcription (Wang et al., 2011). Thus, Pax3 is required to block p53-dependent apoptosis and suppression of Pax3 facilitates p53-dependent apoptosis.

Many recent studies have focused on bioenergetic abnormalities in amyotrophic lateral sclerosis. Both amyotrophic lateral sclerosis patients and two commonly used mutant SOD1 mice (G86R and G93A mice) display increased resting energy expenditure, a hypermetabolic phenotype, and compromised mitochondrial function (Dupuis et al., 2004, 2011; Bouteloup et al., 2009; Funalot et al., 2009; Chiang et al., 2010). These metabolic abnormalities have been associated with activation of the energy sensor AMPK. The activity of AMPK is increased in the spinal cords of mutant SOD1 mice, and reducing AMPK activity either pharmacologically or genetically prevents mutant SOD1-induced motor neuron death *in vitro* (Lim et al., 2012). In this study, we investigated the correlation of AMPK with amyotrophic lateral sclerosis. We found that AMPK activation promoted the apoptosis of embryonic NSCs induced by oxidative stress in SOD1^G93A^ mice. In addition to embryonic NSCs, we should draw attention to adult and transplanted NSCs. The pathological processes of motor neuron degeneration stimulats NSC proliferation and neurogenesis in amyotrophic lateral sclerosis patients and adult SOD1^G93A^ mice (Chi et al., 2006; Guan et al., 2007; Galan et al., 2011). Human NSCs are emerging as a promising cellular therapy for amyotrophic lateral sclerosis. Implanted NSCs secrete high levels of the trophic factors that protect spared motor neurons, integrate into the parenchyma, and may differentiate into neurons, astrocytes, and oligodendrocytes (Hefferan et al., 2012; Teng et al., 2012). However, the survival of transplanted NSCs over time is a challenge because of the altered niche in amyotrophic lateral sclerosis (Liu and Martin, 2006). Therefore, it is important to assess whether AMPK regulates adult NSC proliferation and the survival of implanted NSCs.

In conclusion, our data indicate that activation of the AMPK/Pax3/p53 pathway promotes the apoptosis of SOD1^G93A^ NSCs induced by oxidative stress. Thus, AMPK/Pax3/p53 might represent a novel target for protecting SOD1^G93A^ NSCs from oxidative injury, which might also contribute to amyotrophic lateral sclerosis therapy.
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